Echinocandin B is a lipopeptide antifungal agent belonging to the echinocandin class, derived from the fungus Aspergillus nidulans. It exhibits potent activity against Candida and Aspergillus species by non-competitively inhibiting β-(1,3)-D-glucan synthase, a critical enzyme for fungal cell wall synthesis. Its mechanism of action ensures minimal cross-resistance with other antifungal classes, making it a valuable candidate for treating invasive fungal infections. Echinocandin B serves as a precursor for semisynthetic derivatives like caspofungin, which are clinically utilized due to enhanced stability and efficacy. Its broad-spectrum antifungal properties and targeted mode of action underscore its significance in antifungal research and development.